Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-C19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL)
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.